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To investigate rabies in Massachusetts, we analyzed 
bat rabies test results before and after introduction of rac-
coon variant rabies and after release of revised 1999 US 
Advisory Committee on Immunization Practices recommen-
dations for rabies postexposure prophylaxis. Bat submis-
sions were associated with level of rabies awareness and 
speciﬁ  c postexposure recommendations.
F
or the past 20 years, bat-associated rabies virus variants 
have accounted for most human rabies infections ac-
quired in the United States. Most infections were associat-
ed with reports of minimal, if any, direct contact with a bat, 
which suggested that superﬁ  cial or unrecognized bat bites 
may transmit infection (1–5). In 1999, the Advisory Com-
mittee on Immunization Practices (ACIP) updated their hu-
man rabies prevention guidelines to include consideration 
of rabies postexposure prophylaxis (PEP) in some circum-
stances without recognized direct bat contact (6). Since the 
ﬁ  rst rabid bat was reported in Massachusetts in 1961, test-
ing of rabid animals has been conducted at the state public 
health laboratory (7). Raccoon rabies virus variant (RRV) 
was ﬁ  rst detected in Massachusetts in 1992 and had spread 
throughout most of the state by 1996.
We reviewed bat rabies data for Massachusetts dur-
ing 1985–2009. We analyzed the effect of RRV introduc-
tion on specimen submission, the impact of the 1999 ACIP 
guidelines on specimen submission, and differences in the 
likelihood of rabies infection among bats with different 
submission characteristics.
The Study
From 1985 through 2009, a total of 10,257 bats were 
submitted to the Massachusetts Department of Public 
Health for rabies testing: 8,850 big brown bats (Eptesicus 
fuscus, 86.3%), 1,074 little brown bats (Myotis lucifugus, 
10.5%), 94 Keen long-eared bats (Myotis keenii, 0.9%), 48 
red bats (Lasiurus blossevillii, 0.5%), 17 hoary bats (La-
siurus cinereus, 0.2%), 17 silver-haired bats (Lasionycteris 
noctivagans, 0.2%), 1 zoo-submitted Seychelles fruit bat 
(Pteropus seychellensis), and 156 (1.5%) unspeciated bats. 
The proportion of rabies-positive bats by species was 5.0% 
(443/8,850) big brown bats, 3.6% (39/1,074) little brown 
bats, 23.5% (4/17) hoary bats, 8.3% (4/48) red bats, 5.9% 
(1/17) silver-haired bats, and 3.2% (3/94) Keen long-eared 
bats; 751 (7.3%) of 10,257 bats were not suitable for rabies 
testing. Among all rabies-positive bats, 89.3% were big 
brown bats, 8.0% were little brown bats, and 2.7% were of 
less frequently submitted species. During 2005–2008 (Fig-
ure 1), submissions of little brown bat sharply increased 
then decreased, although the proportion that was rabies 
positive (2%–4%) remained stable.
The average annual number of bat submissions in-
creased signiﬁ  cantly from 103 during 1985–1991 to 302 
during 1992–1998 and to 675 during 1999–2009 (p<0.0001) 
(Figure 2). The average annual number of conﬁ  rmed rabid 
bats increased from 7 to 19 to 28 for those periods, and 
the proportion of bats positive for rabies decreased from 
6.9% (50/720) to 6.4% (135/2,113) to 4.2% (311/7,424). 
The proportion of rabid bats was signiﬁ  cantly lower during 
1999–2009 (p<0.05).
Among 961 testable bats submitted before RRV intro-
duction, 76 (7.9%) were positive for rabies compared with 
420 (4.9%) of 8,545 bats submitted after RRV introduc-
tion. No positive association was identiﬁ  ed between RRV 
introduction and proportion of bats positive for rabies, even 
when adjusting for potential confounders such as bat spe-
cies (big brown and little brown vs. other pooled species), 
reason for bat submission (human and pet exposure, human 
exposure only, and pet exposure only vs. undeﬁ  ned), and 
time of submission (1985–1991 and 1992–1998 vs. 1999–
2009). Limited RRV strain typing results performed on 52 
rabies-positive bats showed that all bats were infected with 
non-RRV (X. Wang et al., unpub. data).
Before publication of the 1999 ACIP recommenda-
tions, the most common reason for testing bats was pet 
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Figure 1. Bats submitted for rabies testing in Massachusetts, USA, 
1985–2009. Black line indicates Eptesicus fuscus, red line indicates 
Myotis lucifugus, and blue line indicates other pooled bats.exposure only, which accounted for 50.3% of submissions 
during 1985–1991 and 43.5% during 1992–1998 (Table 1). 
After 1999, the most common reason for bat testing was 
human exposure, accounting for 72.0% of submissions dur-
ing 1999–2009. Although the number of bat submissions 
because of human exposure increased with time, the rabies-
positive proportion of these bats decreased from 10.3% 
(17/165) to 5.8% (51/885) to 3.8% (204/5,343) during the 
3 periods. No signiﬁ  cant differences in rabies positivity 
among bats submitted for different reasons were found dur-
ing 1999–2009 (Table 2).
Clinical signs were reported for 2,291 (24%) of 9,537 
bats submitted since 1992 (Table 2). The most common 
signs were death (1,206, 52.6%), disorientation (514, 
22.4%), lethargy (358, 15.6%), or aggressiveness (275, 
12.0%). Bats described as having aggression, ataxia, disori-
entation, or lethargy were signiﬁ  cantly more likely to have 
rabies than were bats with no reported signs (p<0.05). Bats 
found dead were no more likely to have rabies than were 
bats reported alive before submission.
Conclusions
The increase in bat submissions for rabies testing af-
ter 1992 correlated with RRV introduction and associated 
statewide enhancement of rabies surveillance and aware-
ness generated by arrival of raccoon rabies. However, in 
contrast to other animal species in which RRV introduction 
resulted in an increase in identiﬁ  cation of rabies (8), the 
proportion of bats with rabies was constant in the periods 
before (1985–1991) and after (1992–1998) RRV introduc-
tion. These ﬁ  ndings are supported by limited laboratory 
typing data in rabid bats, which showed no evidence that 
RRV plays a role in bat infection. This ﬁ  nding is consis-
tent with reports that insectivorous bat rabies virus variants 
circulate separately from terrestrial viral variants (9,10). 
Although incidents of bat rabies virus variant spillover into 
terrestrial mammals are documented (11), spillover of ter-
restrial variants into bats has yet to be reported.
After release of the ACIP guidelines, the number of 
annual bat submissions for rabies testing doubled relative 
to the previous period, and the proportion of rabies-positive 
bats decreased (6.5% vs. 4.2%). Between 1985–1991 and 
1999–2009, the proportion of bats submitted on the basis 
of human exposure (human exposure alone and human and 
pet exposure) increased from 22.9% to 72.0%. This ﬁ  nding 
was likely caused by adherence to the ACIP recommenda-
tions and increased awareness of rabies in bats.
In examining the effect of various bat characteristics 
on the likelihood of rabies infection, we found that signs of 
central nervous system involvement, including aggression, 
ataxia, disorientation, or lethargy, were associated with ra-
bies. However, use of reported bat behavior and appear-
ance in assessing the risk for rabies is not feasible (8).
Big brown bats were submitted in the highest num-
bers, and had the highest rabies positivity. Increases in little 
brown bat submissions began 1 year before identiﬁ  cation 
of bat white-nose syndrome in upstate New York in 2006 
(12). This increase in little brown bat submissions was not 
associated with rabies positivity or with bats found dead as 
a reason for submission.
The role of rabies laboratory testing and public health 
follow-up is reﬂ   ected in part by the number of costly 
courses of PEP potentially averted or discontinued. During 
1999–2009, a total of 4,766 Massachusetts residents were 
exposed to bats that were negative for rabies virus. With 
each course of PEP costing an estimated $2,376 in biolog-
ics alone in 1998 (13), and without considering costs asso-
ciated with medical evaluation and vaccine administration, 
this cost amounts to $10–20 million in healthcare savings 
in Massachusetts in 1999–2009. A recent study of PEP rec-
ommendations for potentially unrecognized bat exposures 
suggests that the rate of human rabies associated with such 
exposures was only 1/2.7 billion person-years, and medical 
costs of such exposures could be up to 2 billion Canadian 
dollars (14). Analyses such as this have already prompted 
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Figure 2. Rabies in bats in Massachusetts, USA, 1985–2009. Black 
line indicates number of bats submitted and red line indicates 
percentage of bats positive for rabies.
Table 1. Reasons for bat submissions for rabies testing, 
Massachusetts, USA, 1985–2009 
Reason 
No. (%) submissions 
1985–1991 1992–1998 1999–2009 
Human and pet 
exposure 
5 (0.7)  250 (11.8)  1,004 (13.5) 
Human exposure 
only 
160 (22.2)  635 (30.1)  4,339 (58.5) 
Pet exposure only  362 (50.3)  918 (43.5)  1,295 (17.4) 
Sickness and other 
reasons
193 (26.8)  310 (14.7)  786 (10.6) 
Total 720 2,113 7,424 Bat Rabies in Massachusetts, USA, 1985–2009
changes in rabies PEP recommendations in Canada to spec-
ify direct exposure to a bat (15). PEP recommendations 
in the United States are based on national guidelines and 
include considerations of PEP for cryptic bat exposures. 
Current practice is in place pending reconsideration of and 
changes to these guidelines.
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